🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Rosacea is a chronic and relapsing inflammatory cutaneous disorder with hig...
Status
Unknown
Location
Multiple Locations
Start Date
2022-05-25
Trial ID
NCT05401422
Treatments Being Tested
This study looks at whether a topical gel called 0.33% brimonidine can redu...
Status
Completed
Location
Istanbul Training and Research Hospital, Department of Dermatology
Start Date
2025-05-01
Trial ID
NCT07431476
Treatments Being Tested
An investigator-blinded, prospective, 6 month study of subjects with persis...
Status
Completed
Location
Dept of Dermatology, WFUHS
Start Date
2016-05-05
Trial ID
NCT03048058
Treatments Being Tested
To survey patients with rosacea about their rosacea treatment preferences a...
Status
Completed
Location
Multiple Locations
Start Date
2015-01-08
Trial ID
NCT02602470
To compare safety and efficacy of Perrigo's rosacea drug product compared t...
Status
Completed
Location
Multiple Locations
Start Date
2015-03
Trial ID
NCT02385240
Taxane -induced peripheral neuropthy (TIPN) and nail toxicites are frequent...
Status
Not Yet Recruiting
Location
Institut Paoli-Calmettes
Start Date
2025-09-01
Trial ID
NCT07082764
Treatments Being Tested
The pilot study will investigate whether combination treatment of Finacea 1...
Status
Completed
Location
DermResearch, PLLC
Start Date
2014-05
Trial ID
NCT02147691
Treatments Being Tested
The main objective of this study is to evaluate the efficacy of Ivermectin ...
Status
Completed
Location
Multiple Locations
Start Date
2015-12
Trial ID
NCT02616250
The purpose of this study is to compare the efficacy and assess the safety ...
Status
Completed
Location
Hudson Dermatology
Start Date
2012-09
Trial ID
NCT01659853
Treatments Being Tested
A Randomized, Double-Blind, Multiple-Site, Placebo-Controlled, Parallel-Des...
Status
Completed
Location
Investigator site 2
Start Date
2014-07
Trial ID
NCT02289352
Treatments Being Tested